(:TSRO)

Jan 09, 2019 08:40 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Jan 08, 2019 09:46 am ET
CLASS ACTION UPDATE for TSRO and PPDF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Jan 08, 2019 08:45 am ET
WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces It is Investigating Claims against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ:
Jan 07, 2019 12:13 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TSRO and MGI
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Jan 07, 2019 10:15 am ET
DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ:
Jan 05, 2019 09:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts,...
Jan 02, 2019 02:17 pm ET
SHAREHOLDER ALERT: ALGN RYAAY RBBN (formerly SONS) TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Jan 01, 2019 01:01 pm ET
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Dec 31, 2018 10:26 am ET
CLASS ACTION UPDATE for TSRO, PPDF and MAR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 30, 2018 10:54 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.  The class action, filed in United States District Court, District of Massachusetts, and...
Dec 29, 2018 04:00 am ET
TSRO LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Case Deadline – TSRO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tesaro, Inc. (NASDAQ: TSRO) from November 4, 2016 through November 14, 2016, inclusive (the “Class...
Dec 28, 2018 07:36 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of BSB Bancorp, Gaming Partners, Tribune Media, and Tesaro on Behalf of Stockholders and Encourages Inves
Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of BSB Bancorp, Inc., Gaming Partners International Corporation, Tribune Media Company, and Tesaro, Inc.  Additional information about...
Dec 28, 2018 01:16 pm ET
Lifshitz & Miller LLP Announces Investigation of Apptio, Inc., Black Box Corporation, CURO Group Holdings Corp., Finisar Corporation, Gaming Partners International Corporation, Resolute Energy Corpora
NEW YORK, Dec. 28, 2018 /PRNewswire/ --  
Dec 26, 2018 12:57 pm ET
CLASS ACTION UPDATE for COST, TSRO, and XPO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 26, 2018 08:30 am ET
EARLY JANUARY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Dec 23, 2018 02:00 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COST, RBBN, TSRO and MGI
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 21, 2018 05:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline - TSRO
NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts, and indexed under 18-cv-12352, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired Tesaro securities between November 4, 2016 through November 14, 2016, both dates inclusive (the "Class Period"), seeking to recover dama
Dec 20, 2018 02:46 pm ET
SHAREHOLDER ALERT: AQUA TSRO MGI MDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 18, 2018 04:14 pm ET
CLASS ACTION UPDATE for TSRO, EIX and MDR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 18, 2018 01:05 pm ET
TSRO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.; Important Deadline – TSRO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tesaro, Inc. (NASDAQ: TSRO) from November 4, 2016 through November 14, 2016, inclusive (the “Class...
Dec 18, 2018 12:20 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Dec 16, 2018 10:05 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IGCC, AQUA, TSRO, MAR and APHA
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 14, 2018 05:33 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States District Court, District of Massachusetts, and...
Dec 14, 2018 01:36 pm ET
SHAREHOLDER ALERT: COST IGCC AQUA TSRO EIX ATUS TS BA CMCM TDOC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 13, 2018 03:26 pm ET
CLASS ACTION UPDATE for APOG, RBBN (SONS and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 12, 2018 02:06 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, IGCC, NKTR, TSRO and APHA
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 11, 2018 04:21 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Dec 10, 2018 03:13 pm ET
SHAREHOLDER ALERT: TRVN GOOG GOOGL CWH HON FIT SYF RYAAY TSRO MGI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 09, 2018 11:07 am ET
CLASS ACTION UPDATE for AQUA, TSRO, MDR and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 07, 2018 04:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts,...
Dec 07, 2018 01:57 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AQUA, SONS, RBBN, TSRO, ATUS and BA
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 06, 2018 01:00 pm ET
SHAREHOLDER ALERT: APOG SFIX GOOG GOOGL CWH ALGN SYF AQUA TSRO MGI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 06, 2018 11:48 am ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Dec 05, 2018 03:11 pm ET
CLASS ACTION UPDATE for GSKY, TSRO and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 04, 2018 07:00 pm ET
SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Tesaro, Inc. - TSRO
NEW YORK, Dec. 4, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors and Officers of Tesaro, Inc. ("Tesaro" or the "Company") (NasdaqGS: TSRO) for possible breaches of fiduciary duty.
Dec 04, 2018 04:15 pm ET
TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that, pursuant to the terms of the indenture (the “Indenture”) governing the terms of its 3.00% Convertible Senior notes due 2021 (the “Notes”), it...
Dec 04, 2018 02:30 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JT, GOOG, AQUA, GSKY, TSRO and EIX
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Dec 04, 2018 08:31 am ET
Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.?
NEW YORK, Dec. 4, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATOS, CRON, NBEV, TSRO, and XXII.
Dec 03, 2018 09:03 pm ET
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Tesaro, Inc. (TSRO) on Behalf of Stockholders and Encourages TSRO Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Tesaro, Inc. (NASDAQ: TSRO) on behalf of stockholders concerning the proposed acquisition of the company by GlaxoSmithKline plc (NYSE: GSK). Pursuant...
Dec 03, 2018 03:36 pm ET
TESARO, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
Rigrodsky & Long, P.A.:
Dec 03, 2018 01:12 pm ET
CLASS ACTION UPDATE for RBBN and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Dec 03, 2018 10:00 am ET
SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers, on behalf of shareholders who...
Dec 03, 2018 08:00 am ET
Detailed Research: Economic Perspectives on TESARO, Regeneron Pharmaceuticals, Pool, Zebra Technologies, Cadence Design, and TherapeuticsMD — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of TESARO, Inc. (NASDAQ:TSRO), Regeneron Pharmaceuticals, Inc....
Dec 03, 2018 07:04 am ET
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) today announced that the Companies have entered into a definitive agreement pursuant to which GSK will acquire TESARO, an oncology-focused company based in Waltham, Massachusetts,...
Dec 03, 2018 06:50 am ET
Tesaro (TSRO) Alert: Johnson Fistel Investigates Proposed Sale of Tesaro, Inc. to GlaxoSmithKline plc; Are Shareholders Getting a Fair Deal?
SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Tesaro, Inc. (NASDAQ: TSRO) ("Tesaro") breached their fiduciary duties in connection with the proposed sale of the Company to GlaxoSmithKline plc (NYSE: GSK) ("Glaxo").
Dec 02, 2018 10:00 am ET
SHAREHOLDER ALERT: APOG SFIX DY FIT RYAAY TSRO MDR ATUS PPDF BA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 30, 2018 05:21 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts,...
Nov 30, 2018 03:00 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOOG, OZK, NKTR, FIT and TSRO
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 29, 2018 06:05 pm ET
TSRO SHAREHOLDER NOTICE: Rosen Law Firm Reminds Tesaro, Inc. Investors of Important Deadline in Class Action – TSRO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tesaro, Inc. (NASDAQ:TSRO) from November 4, 2016 through November 14, 2016, inclusive (the “Class Period”) of the important January 8, 2019 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tesaro investors under the federal securities laws.
Nov 29, 2018 11:59 am ET
CLASS ACTION UPDATE for TSRO, MGI and MDR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 29, 2018 10:00 am ET
SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline - January 9, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers, on behalf of shareholders who...
Nov 28, 2018 02:56 pm ET
SHAREHOLDER ALERT: TGTX ACHC HTHT IGCC ALGN FIT TSRO EIX MDR ATUS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 27, 2018 01:00 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ALGN, RBBN, TSRO, EIX and MDR
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 27, 2018 11:11 am ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Nov 26, 2018 04:36 pm ET
CLASS ACTION UPDATE for COST, TSRO and MGI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 26, 2018 11:21 am ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tesaro, Inc.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tesaro, Inc. (NASDAQ:TSRO) from November 4, 2016 through November 14, 2016, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Tesaro investors under the federal securities laws.
Nov 25, 2018 10:00 am ET
SHAREHOLDER ALERT: MGTI TRVN HTHT IGCC FIT SYF TSRO EIX MDR ATUS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 23, 2018 06:25 pm ET
 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts,...
Nov 23, 2018 11:03 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IGCC, AQUA, RBBN, TSRO, EIX and MDR
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 21, 2018 12:47 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of...
Nov 21, 2018 10:50 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IGCC, FIT, SYF and TSRO
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 20, 2018 04:56 pm ET
CLASS ACTION UPDATE for RBBN (formerly SONS) and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 19, 2018 04:28 pm ET
SHAREHOLDER ALERT: APOG ALNY ACHC COST TRVN SFIX ALGN AQUA TSRO MGI MDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 19, 2018 02:44 pm ET
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ:
Nov 18, 2018 10:15 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FIT, TSRO, MGI and MDR
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 16, 2018 06:21 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ:
Nov 16, 2018 05:07 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro, Inc. of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, District of Massachusetts,...
Nov 16, 2018 10:24 am ET
CLASS ACTION UPDATE for COST, TSRO and MGI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 14, 2018 04:04 pm ET
SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Nov 12, 2018 05:27 pm ET
CLASS ACTION UPDATE for IGCC, ALGN, AQUA and TSRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Nov 09, 2018 08:02 pm ET
Pomerantz Law Firm Announces the Filing of a Class Action against Tesaro, Inc. and Certain Officers – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States District Court, District of Massachusetts, and...
Nov 09, 2018 03:41 pm ET
TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today presented initial data from the Phase 1 AMBER trial of TSR-022 (anti-TIM-3 antibody) in combination with TSR-042 (anti-PD-1 antibody) in patients who have progressed...
Nov 01, 2018 04:05 pm ET
TESARO Announces Third-Quarter 2018 Operating Results
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today reported operating results for third-quarter 2018 and provided an update on the Company's commercial products and development programs. “In the third quarter, we...
Oct 30, 2018 08:05 am ET
The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year
The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology (SGO), and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the third year of their partnership...
Oct 29, 2018 08:00 am ET
TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced the achievement of development milestones that trigger an $18 million payment from Janssen Biotech Inc. (Janssen). The milestones are related to Janssen’s...
Oct 24, 2018 08:35 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within YRC Worldwide, NRG Energy, TESARO, The Trade Desk, Foot Locker, and Hertz Global — New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of YRC Worldwide, Inc. (NASDAQ:YRCW), NRG Energy, Inc. (NYSE:NRG), TESARO,...
Oct 24, 2018 08:00 am ET
TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, announced today the launch of Not on My Watch, a movement to empower the ovarian cancer community, especially women with recurrent ovarian cancer, to take informed and...
Oct 20, 2018 01:30 am ET
TESARO Announces Data Presentations at ESMO 2018 Congress
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today summarized updated Phase 1 GARNET data of TSR-042 (anti-PD-1 antibody) in patients with recurrent or advanced microsatellite instability high (MSI-H) endometrial...
Oct 18, 2018 04:15 pm ET
TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018
TESARO, Inc. (NASDAQ: TSRO) will announce third-quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15...
Oct 09, 2018 08:15 am ET
TESARO Announces Data Presentations at the ESMO 2018 Congress
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that data from six abstracts will be presented at the European Society for Medical Oncology (ESMO) Congress from October 19-23, 2018 in Munich, Germany....
Oct 01, 2018 06:15 pm ET
TESARO Announces Data Presentations at the SITC 2018 Annual Meeting
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that data from a total of five abstracts will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting from November 7-11, 2018 in...
Sep 19, 2018 04:15 pm ET
TESARO Announces Participation at Two Investor Conferences
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:        The Cantor Global Healthcare Conference at the InterContinental New...
Sep 04, 2018 04:15 pm ET
TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced it has initiated the second stage of the JASPER study that is designed to assess clinical benefit of ZEJULA® in combination with an anti-PD-1 antibody in...
Aug 27, 2018 08:00 am ET
TESARO Announces Participation at Three Investor Conferences
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are: Citi’s 13th Annual Biotech Day at the Four Seasons Hotel in Boston on...
Aug 02, 2018 04:05 pm ET
TESARO Announces Second-Quarter 2018 Operating Results
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today reported operating results for second-quarter 2018 and provided an update on the Company's commercial products and development programs. “In the second quarter, we...
Jul 20, 2018 04:15 pm ET
TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018
TESARO, Inc. (NASDAQ:TSRO) will announce second-quarter 2018 financial results on Thursday, August 2, 2018, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15...
Jul 02, 2018 09:00 am ET
TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to announce a new partnership supporting the Pan-Mass Challenge (PMC). The PMC is the nation’s most successful athletic fundraising event, raising money for cancer...
Jun 29, 2018 04:05 pm ET
TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing
TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has drawn the $200 million second tranche under its term loan agreement with BIOPHARMA CREDIT PLC and BIOPHARMA CREDIT INVESTMENTS IV SUB LP,...
Jun 28, 2018 04:05 pm ET
TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into an asset purchase agreement with TerSera Therapeutics LLC (TerSera) under which it will divest North American rights to the oral...
Jun 18, 2018 07:45 am ET
Recent Analysis Shows Enel Américas, ZAGG, DCT Industrial Trust, Community Healthcare Trust, Wabash National, and Tesaro Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enel Américas S.A. (NYSE:ENIA), ZAGG Inc. (NASDAQ:ZAGG), DCT Industrial...
Jun 05, 2018 08:30 am ET
TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with Genentech, a member of the Roche Group, to evaluate the combination of the PD-L1 antibody atezolizumab...
Jun 04, 2018 06:00 pm ET
TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, summarized the results of the TOPACIO and QUADRA trials during an investor briefing held in conjunction with the 2018 American Society of Clinical Oncology (ASCO) Annual...
Jun 01, 2018 03:00 am ET
TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the National Institute for Health and Care Excellence (NICE) will make ZEJULA® (niraparib), the first PARP inhibitor shown to be effective in patients with a...
May 16, 2018 05:15 pm ET
TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of five ZEJULA® (niraparib) abstracts, including two oral presentations, at the 2018 American Society of Clinical Oncology (ASCO) Annual...
May 03, 2018 04:05 pm ET
TESARO Announces First-Quarter 2018 Operating Results
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today reported operating results for first-quarter 2018, and provided an update on the Company's commercial products and development programs. “2018 is off to an...
May 01, 2018 04:15 pm ET
TESARO Announces Participation in Two Investor Conferences
WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:
Apr 24, 2018 07:00 am ET
TESARO Announces Positive Top-Line Results From Quadra Trial of ZEJULA®
WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced results from the QUADRA study, which was designed to assess clinical benefit of ZEJULA® treatment in heavily pre-treated patients with ovarian...
Apr 20, 2018 08:00 am ET
New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International — Consolidated Revenues, Company Growth, and Expectations for 2
NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX), TESARO, Inc. (NASDAQ:TSRO),...
Apr 19, 2018 04:15 pm ET
TESARO to Announce First-Quarter 2018 Financial Results on May 3, 2018
WALTHAM, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce first-quarter 2018 financial results on Thursday, May 3, 2018, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference...
Apr 16, 2018 09:00 am ET
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
CHICAGO, April 16, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today summarized initial data from the Phase 1 GARNET trial of TSR-042 (anti-PD-1 antibody) in patients with microsatellite instability high (MSI-H) endometrial cancer and...
Apr 11, 2018 08:30 am ET
TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel
Mar 26, 2018 04:00 pm ET
Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer
NEW ORLEANS, March 26, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company announced the presentation of maturing data from the TOPACIO trial of niraparib in combination with an anti-PD-1 monoclonal antibody, KEYTRUDA® during a plenary...
Mar 16, 2018 03:53 pm ET
Rosen Law Firm Reminds TESARO, Inc. Investors of Important March 19 Deadline in Class Action– TSRO
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TESARO, Inc. (NASDAQ:TSRO) from March 14, 2016 through January 12, 2018, inclusive (the “Class Period”)...
Mar 14, 2018 04:50 pm ET
TESARO Announces Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that data for ZEJULA, TSR-042 (anti-PD-1 antibody) and the company’s immuno-oncology portfolio will be presented at the 2018 American Association for...
Mar 14, 2018 04:09 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its officers. The class action, filed in United States District Court, for the District of Massachusetts, and docketed under 18-cv-10086, is on behalf of a class consisting of investors who purchased or otherwise acquired the securities of Tesaro between March 14, 2016 and January 12, 2018, both dates inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages caused by
Mar 13, 2018 07:57 pm ET
TSRO INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tesaro Incorporated Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ: TSRO) securities between March 14, 2016 and January 12, 2018, inclusive (the “Class Period”). Tesaro investors have until Marc
Mar 13, 2018 01:14 pm ET
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorp
STEVENSON, Md., March 13, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...
Mar 11, 2018 08:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
NEW YORK, March 11, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its officers.   The class action, filed in United...
Mar 09, 2018 03:26 pm ET
TESARO LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Tesaro Incorporated To Contact The Firm
NEW YORK, March 9, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tesaro Incorporated ("Tesaro" or the "Company") (NASDAQ: TSRO) of the March 19, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Mar 02, 2018 01:37 pm ET
TESARO LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Tesaro Incorporated To Contact The Firm
NEW YORK, March 02, 2018 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:TSRO) of the March 19, 2018 deadline to seek the role...
Mar 01, 2018 04:15 pm ET
TESARO Announces Participation at Two Investor Conferences
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:     
Feb 27, 2018 04:05 pm ET
TESARO Announces Fourth-Quarter and Full-Year 2017 Operating Results
WALTHAM, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today reported operating results for fourth-quarter and full-year 2017, and provided an update on the Company's commercial products and development programs.
Feb 27, 2018 12:00 pm ET
TESARO, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / TESARO, Inc. (NASDAQ: TSRO) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 4:15 PM Eastern Time.
Feb 26, 2018 03:00 pm ET
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer
WALTHAM, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with Genentech, a member of the Roche Group, to evaluate the combination of...
Feb 24, 2018 08:10 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ: TSRO) and certain of its officers. The class action, filed in United States District Court, for the District of Massachusetts, and docketed under 18-cv-10086, is on behalf of a class consisting of investors who purchased or otherwise acquired the securities of Tesaro between March 14, 2016 and January 12, 2018, both dates inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages caused by
Feb 23, 2018 02:47 pm ET
EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. - TSRO
NEW YORK, Feb. 23, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ: TSRO) from March 14, 2016 through January 12, 2018, inclusive (the "Class Period"). The lawsuit seeks to recover damages for TESARO investors under the federal securities laws.
Feb 21, 2018 04:38 pm ET
The Klein Law Firm Reminds Investors of a Class Action on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tesaro, Inc. (NASDAQ:TSRO) who purchased shares between March 14, 2016 and January...
Feb 21, 2018 12:00 pm ET
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for TESARO, Inc. Shareholders
RADNOR, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds TESARO, Inc. (Nasdaq:TSRO) (“TESARO” or the “Company”) shareholders that a class action lawsuit has been filed in the United...
Feb 20, 2018 02:53 pm ET
DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated To
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Tesaro Incorporated (Nasdaq: TSRO) (“Tesaro” or the “Company”) securities during the period between March 14, 2016 and January 12, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 19, 2018 to seek appointment as lead plaintiff.
Feb 17, 2018 07:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline - TSRO
NEW YORK, Feb. 17, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers.   The class action, filed in United States District Court, for the District of Massachusetts, and docketed under 18-cv-10086, is on behalf of a class consisting of investors who purchased or otherwise acquired the securities of Tesaro between March 14, 2016 and January 12, 2018, both dates inclusive (the "Class Period"). Plaintiff seeks to recover compensable damages caused by Defendants'
Feb 16, 2018 07:45 am ET
Research Report Identifies TESARO, Brunswick, Brooks Automation, Infinity Pharmaceuticals, Edison International, and Anthem with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TESARO, Inc. (NASDAQ:TSRO), Brunswick Corporation (NYSE:BC),...
Feb 15, 2018 03:15 pm ET
TSRO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors...
Feb 14, 2018 05:27 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 – TSRO
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
Feb 14, 2018 12:00 pm ET
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed Against TESARO, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against TESARO, Inc. (Nasdaq: TSRO) (“TESARO” or the “Company”) on behalf of purchasers of the Company’s securities between March 14, 2016 and January 12, 2018, inclusive (the “Class Period”).
Feb 12, 2018 10:10 am ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018
NEW YORK, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its...
Feb 10, 2018 11:00 am ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated (Nasdaq: TSRO) To Contact Brower Piven Before The Lead Plaintiff Deadl
STEVENSON, Md., Feb. 10, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...
Feb 10, 2018 08:02 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
NEW YORK, Feb. 10, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its officers.   The class action, filed in United...
Feb 08, 2018 04:36 pm ET
TESARO Notice: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. – TSRO
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ:TSRO) from March...
Feb 06, 2018 02:00 pm ET
The Klein Law Firm Reminds Investors that a Class Action Has Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tesaro, Inc. (NASDAQ: TSRO) who purchased shares between March 14, 2016 and January 12, 2018. The action, which was filed in the United States District Court for the District of Massachusetts, alleges that the Company violated federal securities laws.
Feb 05, 2018 07:30 pm ET
Lawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders Foundation
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ:TSRO shares over alleged Securities Laws Violations by TESARO Inc.
Feb 05, 2018 04:15 pm ET
TSRO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Tesaro, Inc. ("Tesaro") (NASDAQ: TSRO) securities between March 14, 2016 and January 12, 2018.
Feb 02, 2018 03:40 pm ET
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018
The following statement is being issued by Levi & Korsinsky, LLP:
Feb 02, 2018 02:44 pm ET
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Tesaro Incorporated Investors and Encourages Investors to Contact the Firm (TSRO)
Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ: 
Feb 02, 2018 09:48 am ET
TESARO to Announce Fourth-Quarter 2017 Financial Results on February 27, 2018
WALTHAM, Mass., Feb. 02, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce fourth-quarter 2017 financial results on Tuesday, February 27, 2018, after the close of the U.S. financial markets. During the conference call and live audio webcast...
Feb 01, 2018 04:59 pm ET
The Klein Law Firm Announces a Class Action Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tesaro, Inc. (NASDAQ: TSRO) who purchased shares between March 14, 2016 and January 12, 2018. The action, which was filed in the United States District Court for the District of Massachusetts, alleges that the Company violated federal securities laws.
Feb 01, 2018 11:32 am ET
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Tesaro, Inc. - TSRO
RADNOR, Pa., Feb. 1, 2018 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against TESARO, Inc. (Nasdaq: TSRO) ("TESARO" or the "Company") on behalf of purchasers of the Company's securities between March 14, 2016 and January 12, 2018, inclusive (the "Class Period").
Jan 31, 2018 04:46 pm ET
The Klein Law Firm Announces a Class Action Filed on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018
NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tesaro, Inc. (NASDAQ:TSRO) who purchased shares between March 14, 2016 and January...
Jan 30, 2018 11:21 am ET
TSRO INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Tesaro, Inc. ("Tesaro") (NASDAQ: TSRO) securities between March 14, 2016 and January 12, 2018.
Jan 29, 2018 01:03 pm ET
TSRO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors...
Jan 28, 2018 05:30 am ET
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Tesaro Incorporated to Contact Brower Piven Bef
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Tesaro Incorporated (Nasdaq: TSRO) (“Tesaro” or the “Company”) securities during the period between March 14, 2016 and January 12, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 19, 2018 to seek appointment as lead plaintiff.
Jan 26, 2018 01:58 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tesaro, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018
The following statement is being issued by Levi & Korsinsky, LLP:
Jan 26, 2018 12:49 pm ET
TSRO LOSS NOTICE: Rosen Law Firm Reminds TESARO, Inc. Investors of Important Deadline in Class Action– TSRO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TESARO, Inc. (NASDAQ: TSRO) from March 14, 2016 through January 12, 2018, inclusive (the “Class Period”) of the important March 19, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for TESARO investors under the federal securities laws.
Jan 25, 2018 11:29 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 – TSRO
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
Jan 25, 2018 10:10 am ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its...
Jan 24, 2018 10:00 am ET
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Tesaro, Inc.
The Klein Law Firm announces the commencement of an investigation of Tesaro, Inc. (NASDAQ: TSRO) concerning possible violations of federal securities laws.
Jan 23, 2018 02:41 pm ET
TSRO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Tesaro, Inc. Investors
Law Offices of Howard G. Smith continues its investigation on behalf of Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) investors concerning the Company and its officers’ possible violations of federal securities laws.
Jan 23, 2018 11:35 am ET
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Tesaro, Inc.
The Klein Law Firm announces the commencement of an investigation of Tesaro, Inc. (NASDAQ: TSRO) concerning possible violations of federal securities laws.
Jan 22, 2018 12:55 pm ET
TSRO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tesaro, Inc.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:TSRO) violated federal securities laws.
Jan 22, 2018 11:00 am ET
Glancy Prongay & Murray LLP Continues Investigation on Behalf of Tesaro, Inc. Investors (TSRO)
Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:
Jan 20, 2018 11:49 pm ET
Lifshitz & Miller LLP Announces Investigation of AMC Entertainment Holdings, Inc., Acuity Brands, Inc., Aradigm Corporation, Intel Corporation, SCANA Corporation, Tesaro, Inc. and Tucows Inc.
NEW YORK, Jan. 21, 2018 /PRNewswire/ --
Jan 19, 2018 03:37 pm ET
Robbins Arroyo LLP: Tesaro, Inc. (TSRO) Misled Shareholders According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that investors filed a class action complaint against Tesaro, Inc. (NasdaqGS: TSRO). The complaint is brought on behalf of all purchasers of Tesaro securities between March 14, 2016 and January 12, 2018, for alleged violations of the Securities Exchange Act of 1934 by Tesa
Jan 19, 2018 12:38 pm ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018
NEW YORK, Jan. 19, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) and certain of its officers, on behalf of shareholders who purchased Tesaro securities during the period between March 14, 2016 and January 12, 2018, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/tsro.
Jan 19, 2018 10:00 am ET
TSRO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tesaro, Inc.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:TSRO) violated federal securities laws.
Jan 18, 2018 08:30 pm ET
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated (Nasdaq: TSRO) To Contact B
STEVENSON, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of...
Jan 18, 2018 01:29 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Tesaro, Inc. Investors
Law Offices of Howard G. Smith announces an investigation on behalf Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ: TSRO) concerning the Company and its officers’ possible violations of federal securities laws.
Jan 18, 2018 10:39 am ET
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tesaro, Inc.
Levi & Korsinsky announces it has commenced an investigation of Tesaro, Inc. (NASDAQ: TSRO) concerning possible violations of federal securities laws.
Jan 18, 2018 09:40 am ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. – TSRO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ: TSRO) from March 14, 2016 through January 12, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for TESARO investors under the federal securities laws.
Jan 17, 2018 03:33 pm ET
Pomerantz Law Firm Announces the Filing of a Class Action against Advanced Tesaro Incorporated and Certain Officers – TSRO
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:TSRO) and certain of its officers.   The class action, filed in United...
Jan 17, 2018 02:43 pm ET
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Tesaro, Inc. Investors (TSRO)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Tesaro, Inc. (“Tesaro” or the “Company”) (NASDAQ:
Jan 17, 2018 10:55 am ET
TESARO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Tesaro, Inc. To Contact The Firm
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ:TSRO).
Jan 16, 2018 04:48 pm ET
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against TESARO, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ:TSRO) resulting from allegations that TESARO may have issued materially misleading business information to the investing public.
Jan 16, 2018 04:12 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tesaro, Inc.
Levi & Korsinsky announces it has commenced an investigation of Tesaro, Inc. (NASDAQ:TSRO) concerning possible violations of federal securities laws.
Jan 16, 2018 10:57 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tesaro, Inc. (TSRO)
NEW YORK, Jan. 16, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO) . Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/tsro.
Jan 16, 2018 10:50 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesaro, Inc. - TSRO
NEW YORK, Jan. 16, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tesaro, Inc. ("Tesaro" or the "Company") (NASDAQ: TSRO).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Jan 12, 2018 05:30 pm ET
TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
WALTHAM, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has updated the VARUBI® (rolapitant) injectable emulsion package insert in collaboration with the U.S. Food and Drug Administration (FDA)....
Dec 15, 2017 04:00 am ET
TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany
ZUG, Switzerland, Dec. 15, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, announced today that ZEJULA® (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, is now available by prescription in Germany. ZEJULA is also...
Dec 01, 2017 08:00 am ET
Market Trends Toward New Normal in Infinity Pharmaceuticals, Edison International, Anthem, TESARO, Brunswick, and BroadSoft — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Edison...
Nov 28, 2017 08:00 am ET
TESARO Announces Availability of VARUBI® (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States
WALTHAM, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that VARUBI® (rolapitant) IV, is now available in the United States. The U.S. Food and Drug Administration (FDA) approved VARUBI injectable...
Nov 22, 2017 04:05 pm ET
TESARO Announces Participation in Two Investor Conferences
WALTHAM, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:
Nov 21, 2017 08:00 am ET
TESARO Secures $500 Million Non-Dilutive Term Loan Financing
WALTHAM, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has entered into a definitive term loan agreement with BIOPHARMA CREDIT PLC and BIOPHARMA CREDIT INVESTMENTS IV SUB...
Nov 20, 2017 08:00 am ET
TESARO’s Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year®
WALTHAM, Mass., Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to announce that co-founders Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO, have been named EY Entrepreneurs of the...
Nov 20, 2017 07:00 am ET
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer
ZUG, Switzerland, Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that the European Commission (EC) has granted marketing authorization for ZEJULA® (niraparib) as a monotherapy for the maintenance treatment of...
Nov 07, 2017 04:05 pm ET
TESARO Announces Third-Quarter 2017 Operating Results
ZEJULA® was the most prescribed PARP inhibitor in U.S. with Q3 net sales of $39.4 millionPositive CHMP opinion issued for ZEJULA in E.U.; commercial launch anticipated to begin by year-endExpansion of niraparib development program underway for multiple tumor typesVARUBI® IV approved by U.S. FDA; commercial launch planned for NovemberPhase 1 combination study of TSR-022 (anti-TIM-3) and TSR-042 (anti-PD-1) now enrolling patientsPhase 1 study of TSR-033 (anti-LAG-3) now enrolling patients WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biophar...
Nov 07, 2017 04:05 pm ET
TESARO Announces Third-Quarter 2017 Operating Results
WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today reported operating results for third-quarter 2017 and provided an update on the Company's commercial products and development programs.
Oct 24, 2017 04:15 pm ET
TESARO to Announce Third-Quarter 2017 Financial Results on November 7, 2017
WALTHAM, Mass., Oct. 24, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its third-quarter 2017 financial results on Tuesday, November 7, 2017, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 7, 2017 to discuss the Company’s operating results in greater detail, as well as the status of its development programs and the VARUBI/Y® and ZEJULA® launches....
Oct 23, 2017 04:15 pm ET
TESARO Announces Participation at Two Investor Conferences
WALTHAM, Mass., Oct. 23, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:...
Oct 18, 2017 08:00 am ET
The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer
CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology, and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the continuation of their partnership supporting the annual National Race to End Women’s Cancer. TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer, the FWC’s pinnacle awareness and fundraising event, bringing families and friends from across the country together to support women with ...
Sep 11, 2017 08:00 am ET
TESARO Summarizes ZEJULA and TSR-042 Data Presented at the 2017 ESMO Annual Meeting
MADRID, Spain, Sept. 11, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today provided a summary of ZEJULA and TSR-042, an anti-PD-1 antibody, data presented at the 2017 European Society of Medical Oncology (ESMO) Annual Meeting in Madrid....
Aug 23, 2017 04:15 pm ET
TESARO Announces Participation at Four Investor Conferences
WALTHAM, Mass., Aug. 23, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The four conferences are:...
Aug 08, 2017 04:05 pm ET
TESARO Announces Second-Quarter 2017 Operating Results
ZEJULA is the most prescribed PARP inhibitor in U.S.; Q2 net sales totaled $26 million in first quarter of availabilityRecently opened European niraparib EAP has enrolled 200 patientsVARUBY oral launch now underway in Europe Dose-escalation of TSR-022 (anti-TIM-3) completed and combination trial with TSR-042 (anti-PD-1) initiatedRegulatory strategy defined with FDA for TSR-042 in MSI-high cancers and registration study ongoingLicense agreement signed with Takeda in July for niraparib development and commercialization in Japan and certain other countries with a $100 million upfront payment and ...
Jul 25, 2017 04:15 pm ET
TESARO to Announce Second-Quarter 2017 Financial Results on August 8, 2017
WALTHAM, Mass., July 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its second-quarter 2017 financial results on Tuesday, August 8, 2017, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on August 8, 2017 to discuss the Company’s operating results in greater detail, as well as the status of its development programs and the VARUBI/Y® and ZEJULATM launches....
Jun 29, 2017 09:00 am ET
TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference
WALTHAM, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to support the Ovarian Cancer Research Fund Alliance (OCRFA) as the Presenting Sponsor of the 2017 Ovarian Cancer National Conference, being held July 7-9 in Chicago, IL. The OCRFA National Conference is the largest and longest-running conference for women living with ovarian cancer and their caregivers, bringing together more than 400 survivors, caregivers, researchers, and advocates to hear about the latest innovations in ovarian cancer, find hope and inspir...
Jun 26, 2017 04:15 pm ET
TESARO Joins Healthcare Businesswomen’s Association as Corporate Partner
WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to support the Healthcare Businesswomen’s Association (HBA) as a Corporate Partner. HBA is the leading global organization committed to furthering the advancement and impact of women in healthcare. The organization accomplishes its mission through strong business networks, education, research, advocacy and recognition for individuals and companies....
Jun 07, 2017 04:30 pm ET
TESARO Announces Participation at Goldman Sachs 38th Annual Global Healthcare Conference
WALTHAM, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation at the Goldman Sachs 38th Annual Global Healthcare Conference, to be held June 13-15, 2017 at the Terranea Resort in Rancho Palos Verdes, California. Tim Pearson, EVP and CFO of TESARO, will present at 10:40 AM PT on June 15 and will participate in meetings with investors....
Jun 03, 2017 06:30 pm ET
TESARO Provides Business and Pipeline Update at ASCO Investor Briefing
Initial TOPACIO data for niraparib plus KEYTRUDA® is indicative of potentially synergistic anti-tumor activity in platinum-resistant ovarian cancerPhase 1 results for TSR-042 show anti-PD-1 activityThree posters presented during ASCO describe additional analyses of NOVA dataRobust demand continues for ZEJULA™VARUBI® IV PDUFA date is October 25, 2017VARUBY® oral launch now underway in Germany CHICAGO, June 03, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today described initial data from the TOPACIO trial of niraparib plus KEYTRUDA® (p...
May 25, 2017 04:15 pm ET
Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Investor briefing to be webcast from Chicago on June 3, 2017 at 6:15 PM CT WALTHAM, Mass., May 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of three ZEJULA™ (niraparib) abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2 to June 6, 2017, in Chicago. In addition, TESARO will host an investor and analyst briefing in Chicago on Saturday, June 3 at 6:00 PM local time in conjunction with the ASCO Annual Meeting....
May 01, 2017 08:30 am ET
TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDA
WALTHAM, Mass., May 01, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the submission of an Investigational New Drug (IND) Application for TSR-033 to the U.S. Food and Drug Administration. TSR-033 is a monoclonal antibody targeting LAG-3....
Apr 25, 2017 04:15 pm ET
Tesaro Announces Participation in Two Investor Conferences
WALTHAM, Mass., April 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:...
Apr 25, 2017 04:15 pm ET
TESARO to Announce First-Quarter 2017 Financial Results on May 9, 2017
WALTHAM, Mass., April 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its first-quarter 2017 financial results on Tuesday, May 9, 2017, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on May 9, 2017 to discuss the Company’s operating results in greater detail, as well as the status of its development programs and the VARUBI® and ZEJULATM launches....
Apr 19, 2017 04:15 pm ET
TESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.
ZEJULA is the first and only PARP inhibitor to be approved for the maintenance treatment of women with recurrent ovarian cancerZEJULA is the only PARP inhibitor that has demonstrated a clinically meaningful increase in PFS regardless of BRCA mutation or biomarker statusWALTHAM, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that ZEJULA™ (niraparib), an oral, once-daily poly(ADP-ribose) polymerase (PARP) inhibitor, is now available by prescription in the United States. The U.S. Food and Drug Administration ...
Mar 27, 2017 04:47 pm ET
TESARO Announces U.S. FDA Approval Of ZEJULA™ (Niraparib) For Women With Recurrent Ovarian Cancer
WALTHAM, Mass., March 27, 2017 /PRNewswire/ -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEJULA™ (niraparib), an oral, once-daily poly(ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy. ZEJULA is the first PARP inhibitor to be approved by the FDA that does not require BRCA mutation or other
Mar 27, 2017 03:45 pm ET
TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer
Expanded niraparib ovarian cancer program intended to potentially transform the treatment of front-line ovarian cancerNew breast cancer clinical program for niraparib to address greatest area of unmet need and broader patient populationBRAVO trial no longer expected to serve as a registration study Niraparib in combination with an anti-PD-1 antibody to be developed for front-line, non-small cell lung cancerInvestor conference call and webcast to be held at 4:30 PM ET today WALTHAM, Mass., March 27, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical co...
Mar 12, 2017 08:38 am ET
TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer
WALTHAM, Mass., March 12, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced two niraparib presentations at the 2017 Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer, March 12 to 15, 2017, in National Harbor, Maryland....
Mar 03, 2017 09:41 am ET
Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose
CHICAGO, March 3, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXS, IONS, MDCO, PRTA, and TSRO.
Feb 28, 2017 04:05 pm ET
TESARO Announces Fourth-Quarter 2016 Operating Results
Niraparib NDA under review by FDA; pre-launch preparations for planned commercial launch well underwayExpanded access program (EAP) for niraparib open in U.S.; European EAP expected to open 1H 2017Positive opinion rendered for VARUBY® by the European Medicine Agency’s CHMP; European launch planned for 2Q 2017International headquarters and European operations established to cover 17 target countriesRegistration program for niraparib in lung cancer to be finalized in 1H 2017TSR-042 (anti-PD-1 antibody) registration program to initiate in 2Q 2017Cash and cash equivalents totaled approximately $78...
Feb 21, 2017 04:15 pm ET
TESARO Announces Participation at Two Investor Conferences
WALTHAM, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:...
Feb 14, 2017 04:05 pm ET
Tesaro to Announce Fourth-Quarter 2016 Financial Results on February 28, 2017
WALTHAM, Mass., Feb. 14, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its fourth-quarter 2016 financial results on Tuesday, February 28, 2017, after the close of the U.S. financial markets. TESARO’s senior management will host a conference call and live audio webcast at 4:15 p.m. ET on February 28, 2017 to discuss the Company’s operating results in greater detail, as well as the status of its development programs and the VARUBI® launch....
Feb 02, 2017 04:15 pm ET
Tesaro Announces Participation at Two Investor Conferences
WALTHAM, Mass., Feb. 02, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:...
Jan 11, 2017 11:30 pm ET
TESARO Receives Complete Response Letter for Rolapitant IV from U.S. FDA
No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not requiredInvestor conference call and webcast scheduled for tomorrow at 8:30AM ET WALTHAM, Mass., Jan. 11, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the rolapitant IV New Drug Application (NDA) for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetoge...
Nov 21, 2016 04:05 pm ET
Tesaro Announces Participation in Three Investor Conferences
WALTHAM, Mass., Nov. 21, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are:...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More